- Home
- PFIS vs AGMB Comparison
PFIS vs AGMB Comparison
Compare PFIS & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFIS | AGMB |
|---|---|---|
| Founded | 1905 | 2017 |
| Country | United States | Belgium |
| Employees | N/A | 62 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 589.6M | 562.4M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | PFIS | AGMB |
|---|---|---|
| Price | $67.12 | $12.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $56.00 | $32.00 |
| AVG Volume (30 Days) | 67.7K | ★ 124.1K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | ★ 493.94 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.01 | N/A |
| Revenue Next Year | $5.85 | $17.86 |
| P/E Ratio | $45.66 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.77 | $8.75 |
| 52 Week High | $68.61 | $17.82 |
Technical Indicators
Market Signals| Indicator | PFIS | AGMB |
|---|---|---|
| Relative Strength Index (RSI) | 68.55 | 52.66 |
| Support Level | $56.60 | $9.54 |
| Resistance Level | N/A | $12.83 |
| Average True Range (ATR) | 1.87 | 1.74 |
| MACD | 0.33 | 0.20 |
| Stochastic Oscillator | 80.29 | 38.16 |
Price Performance
Historical ComparisonAbout PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, equipment finance, working capital lines of credit, and construction loans, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
About AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.